Silencing of UCA1 inhibited most pathological progression in PCOS, including GC proliferation, ovary structural damage, serum insulin release and pro-inflammation production, through the suppression of AKT signaling pathway activation. This evidence concerns the gene UCA1 and polycystic ovary syndrome.